My title

  Medical Staff Updates

Zika Virus Update

by Medical Staff Office on June 23, 2016

An update from Mary Clance, MD, hospital epidemiologist: It has now been six months since the epidemic of Zika virus in South America came to the attention of U.S. public health authorities. During that time, the transmission zone has expanded northward from Brazil and now includes more than 25 countries in the Caribbean, South and Central America and Mexico. Local transmission is dependent upon two mosquito species, Aedes aegypti and albopictus, which have been established in the U.S. following importation from overseas. Both are now present in Maryland.

As of June 1, 2016, a total of 21 cases of Zika virus infection have been reported in Maryland. All were acquired in an area of known transmission outside of the U.S.

The West Nile Virus, a related Flavivirus, was imported (by humans) into the U.S. in 1999, and has since become established even though the vector mosquito (Culex) primarily feeds on birds and is less aggressive compared to the Aedes mosquitos, which are aggressive biters that prefer humans.

Considering the magnitude of international travel in this hemisphere, urban crowding, the presence of the vector mosquito adapted to both urban and suburban environments, the fact that most human infections are asymptomatic and therefore undetected, and entry into the summer mosquito season in the northern hemisphere, it is very probable that the Zika virus will become established in the U.S.

Old-fashioned public health measures regarding control of the vector are needed. This includes the removal of stagnant water sources that are mosquito breeding sites and the selective use of pesticides for both larvae and adults. Individual vigilance and tactics to avoid exposure to and bites by mosquitos are especially important this summer.


AAMC Hosts First-Ever Virtual Grand Rounds

by Medical Staff Office on June 23, 2016

The James and Sylvia Earl Simulation to Advance Innovation and Learning (SAIL) Center recently hosted a first-of-its-kind virtual grand rounds based on simulation and surgical education and research. Adrian Park, MD, chair of the Department of Surgery, kicked off this new series of grand rounds sponsored by the American College of Surgeons and their Accredited Education Institutes.

Ivan George, director of the Earl SAIL Center, led the concept, development and implementation of the event. He conceptualized a novel and low-cost interactive video platform bringing together surgeons, researchers and medical experts from 30 facilities and 17 time zones at once to discuss the latest in surgical and simulation methodologies. Leaders participated from organizations such as Mayo Clinic, Cleveland Clinic, Cedar Sinai, and Tripler Army Medical Center, along with institutes in Greece, France, and many others.

Inaugural speaker Dr. Park provided an overview of his 11 years of experience in clinical video conference-based grand rounds, sharing wisdom learned over the years. Guest speaker Mark Pinsky, a dentist, international airline captain, and aviation expert, discussed how aviation methodologies can be applied to surgical processes. He presented a concept of adapting the use of aviation checklists as an organizational tool to empower each member of the surgical team to organize thoughts, identify errors, and increase situational awareness. Combining such systematic solutions with simulation practice could have a positive impact on improving quality and outcomes. The presentation fostered a lively discussion among practitioners and experts across many centers about translating the aviation principles into practice.

This groundbreaking event — for both simulation and surgical grand rounds — provided a unique opportunity for AAMC as discussion leaders. The Earl SAIL Center plans to continue its involvement in this new series of grand rounds in the future. If you would like more information, contact Ivan George at 443-481-6053. Read more about how airline industry strategies are being adapted for medicine.

Outpatient Home Therapy

by Medical Staff Office on April 29, 2016

The Joint Center at AAMC is piloting a program for joint replacement patients where an in-home evaluation is provided by an outpatient physical therapist to review the patient’s function prior to surgery. The therapist assesses the patient’s home and provides recommendations for set up changes to make before surgery to improve patient safety. Once they return home, the patient will receive one or two additional in-home therapy sessions before their transition to outpatient rehab. This program provides opportunity for a quicker discharge and a shorter length of stay, while maintaining quality care. The pilot program is rolling out doctor by doctor until all joint patients are included. The long-term goal is to expand this program beyond The Joint Center patients to other surgical programs at the hospital. For more information on in-home PT, contact Amanda Adkins at 443-481-1418 or

Medical Staff In The News: March/April 2016

by Medical Staff Office on April 29, 2016

New COO Announced

by Medical Staff Office on April 29, 2016

Maulik S. Joshi, DrPH, will join Anne Arundel Medical Center on May 16 as Executive Vice President of Integrated Care Delivery and Chief Operating Officer (EVP and COO). This “next-generation COO” is a new, transformational position for AAMC, and one that will help the organization to continue to move toward Vision 2020: Living Healthier Together. Maulik will help shape the future of healthcare delivery both at AAMC and in Maryland.

Maulik has more than 24 years of varied healthcare experience and currently serves as the Associate Executive Vice President at the American Hospital Association (AHA) and President of the Health Research & Educational Trust. He brings a unique skill set to this new role that will advance AAMC’s work in service excellence, quality, wellbeing, health equity and population health. Through Maulik’s leadership, AAMC will continue to broaden capabilities in population health while maintaining our focus on providing the highest quality, safety and service, delivering on patient- and family-centered care, and driving best practices. In addition to his work with the AHA, Maulik is a published author on the topic of healthcare transformation. His leadership and experience will be invaluable as AAMC continues to grow in the areas of population health and delivering care outside the walls of the hospital.

Maulik is no stranger to AAMC. He has served as an AAMC Board Trustee for the past five years and has chaired the Board Quality and Patient Safety Committee. After seven years of commuting to Chicago, joining AAMC as EVP and COO allows him to be closer to his family and home on the Eastern Shore. More details regarding Maulik’s arrival will be shared with you in the coming weeks.

Joint Outcomes Report

by Medical Staff Office on April 29, 2016

The second annual AAMC Joint Outcomes Report: provides a summary of the joint replacement program’s patient-reported outcomes, clinical measures, and operational and financial data. New to this year’s report is a specific focus on the Multidisciplinary Rapid Recovery Protocol. Now in its second year of implementation, this integrated, patient-centered care model is driving continuous improvement across the full continuum of care for our patients.

Consistently ranked the highest-volume joint replacement program in the state, AAMC now performs more than 2,000 surgeries each year—the first program in Maryland to do so. Patients not only come to our program from all across Maryland, but from all over the country to regain independence and improve their quality of life. Now in its second year of publication, this report highlights the many notable achievements of our program. We believe publishing these healthcare outcomes enhances our culture of continuous improvement and increases value for patients.  At AAMC, our joint replacement team is dedicated to continuously improving the care of our patients, and our program is proud to be a leader in presenting transparent results.

Click here to read the report.

Research Update: Using BioZorb Implant to Define Tumor Removal Site After a Lumpectomy

by Medical Staff Office on April 29, 2016

The Fortney Breast Center is enrolling patients for a study collecting information about the BioZorb tissue marker. BioZorb is an FDA-approved, three-dimensional device a surgeon places after removing tissue from the breast. The study focuses on BioZorb’s use during and after surgery to locate the exact site of tissue removal. To learn more, contact Reema Andrade, clinical research coordinator, at x5749.

Research Update: Clinical Trial: Cholesterol-Lowering Drugs

by Medical Staff Office on April 29, 2016

James Welker, DO, and the Research Institute are conducting a clinical trial studying the effectiveness of Bococizumab, a PCSK9 Inhibitor. This is a new class of drug shown to drastically reduce LDL cholesterol levels in patients with high cholesterol. These patients include those whose LDL cholesterol level remains high despite taking cholesterol-lowering medications and patients who cannot tolerate other cholesterol-lowering medication. If you or someone you know would benefit from learning more about this study, contact Kathy Gray, RN, at x5868 or Kristine Wood, RN, at x5738.

Older posts «

» Newer posts